Serovar
|
USA/%
|
Europe/%
|
China/%
|
Vietnam/%
|
Total¶
|
---|
1
|
1/50
|
14/11.6
|
3/30
|
1/4
|
19
|
2
|
0/0
|
0/0
|
0/0
|
6/24
|
6
|
4
|
1/50
|
12/9.9
|
1/10
|
4/16
|
18
|
5/12
|
0/0
|
8/6.6
|
4/40
|
1/4
|
13
|
6
|
0/0
|
6/5
|
0/0
|
1/4
|
7
|
7
|
0/0
|
7/5.8
|
0/0
|
1/4
|
8
|
8
|
0/0
|
17/14
|
1/10
|
1/4
|
19
|
9
|
0/0
|
12/9.9
|
0/0
|
6/24
|
18
|
10
|
0/0
|
12/9.9
|
0/0
|
3/12
|
15
|
13
|
0/0
|
7/5.8
|
1/10
|
0/0
|
8
|
14
|
0/0
|
1/0.8
|
0/0
|
0/0
|
1
|
15
|
0/0
|
17/14
|
0/0
|
0/0
|
17
|
NT
|
0/0
|
8/6.6
|
0/0
|
1/4
|
9
|
Total§
|
2/100
|
121/100
|
10/100
|
25/100
|
158
|
- ¶Sum of number of serovars in each row.
- §Sum of number of serovars in each column.
- There were no nasal G. parasuis isolates submitted from Canada.